Literature DB >> 28323674

Emergency Presentation of Esophagogastric Cancer: Predictors and Long-term Prognosis.

Sheraz R Markar1, Hugh Mackenzie1, Sara Jemal1, Omar Faiz1,2, David Cunningham3, George B Hanna1.   

Abstract

OBJECTIVE: To identify patient factors that are associated with emergency presentation of esophageal and gastric cancer, and further to evaluate long-term prognosis in this cohort.
BACKGROUND: The incidence of emergency presentation is variable, with the prognosis of patients stabilized and discharged to return for elective surgery unknown.
METHODS: The primary admission of patients with esophageal or gastric cancer within the Hospital Episode Statistics database (1997-2012) was used to classify as emergency or elective diagnosis. Multivariate regression analyses were used to identify patient factors associated with emergency diagnosis and prognosis.
RESULTS: A total of 35,807 (29.4%) and 45,866 (39.6%) patients with esophageal and gastric cancer presented as an emergency over the study period. Age ≥70, female sex, non-white ethnicity, Charlson comorbidity index score ≥3 and more deprived Townsend index were independent predictors of emergency cancer diagnosis. Emergency diagnosis was an independent predictor of increased 5-year mortality for all patients with esophageal cancer [hazard ratio (HR) = 1.63, 95% confidence interval (CI) 1.61-1.65] and gastric cancer (HR = 1.20, 95% CI 1.16-1.23). Specifically patients receiving surgery on an elective follow-up admission with an initial emergency diagnosis had a poorer prognosis (esophageal cancer: HR = 1.35, 95% CI 1.27-1.44, gastric cancer: HR = 1.13. 95% CI 1.04-1.22), with a significant increase in liver recurrence (esophageal cancer: 7.1% vs 4.9%; P < 0.001, gastric cancer: 7.0% vs 4.8%; P < 0.001) compared to patients referred electively.
CONCLUSIONS: Emergency presentation of esophageal and gastric cancer is associated with a poor prognosis, due to the increased incidence of metastatic disease at diagnosis and a higher recurrence rate after surgery.

Entities:  

Mesh:

Year:  2018        PMID: 28323674     DOI: 10.1097/SLA.0000000000002224

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Emergency surgery for gastrointestinal cancer: A nationwide study in Japan based on the National Clinical Database.

Authors:  Nobuaki Hoshino; Hideki Endo; Koya Hida; Nao Ichihara; Yoshimitsu Takahashi; Hiroshi Hasegawa; Toshimoto Kimura; Yuko Kitagawa; Yoshihiro Kakeji; Hiroaki Miyata; Takeo Nakayama; Yoshiharu Sakai
Journal:  Ann Gastroenterol Surg       Date:  2020-06-21

Review 2.  Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms.

Authors:  Cristina Renzi; Aradhna Kaushal; Jon Emery; Willie Hamilton; Richard D Neal; Bernard Rachet; Greg Rubin; Hardeep Singh; Fiona M Walter; Niek J de Wit; Georgios Lyratzopoulos
Journal:  Nat Rev Clin Oncol       Date:  2019-07-26       Impact factor: 66.675

Review 3.  Oesophageal cancer.

Authors:  Elizabeth C Smyth; Jesper Lagergren; Rebecca C Fitzgerald; Florian Lordick; Manish A Shah; Pernilla Lagergren; David Cunningham
Journal:  Nat Rev Dis Primers       Date:  2017-07-27       Impact factor: 52.329

4.  Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer.

Authors:  Sheraz R Markar; Tom Wiggins; Stefan Antonowicz; Sung-Tong Chin; Andrea Romano; Konstantin Nikolic; Benjamin Evans; David Cunningham; Muntzer Mughal; Jesper Lagergren; George B Hanna
Journal:  JAMA Oncol       Date:  2018-07-01       Impact factor: 31.777

5.  Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?

Authors:  N F van Erp; C W Helsper; P Slottje; D Brandenbarg; F L Büchner; K M van Asselt; Jwm Muris; M F Kortekaas; Phm Peeters; N J de Wit
Journal:  United European Gastroenterol J       Date:  2020-04-06       Impact factor: 4.623

6.  Factors associated with oesophagogastric cancers missed by gastroscopy: a case-control study.

Authors:  Foong Way David Tai; Nicholas Wray; Reena Sidhu; Andrew Hopper; Mark McAlindon
Journal:  Frontline Gastroenterol       Date:  2019-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.